COVID-19 Vaccine Provider Weekly Updates

Stay Safe MN logo

COVID-19 Vaccine Provider Weekly Updates

View this as a webpage

Minnesota Department of Health

August 12, 2021


Good afternoon,

Here are the COVID-19 vaccine provider updates for August 6 to August 12, 2021.

COVID-19 vaccine ordering updates in preparation for new additional dose recommendations

We are anticipating an emergency use authorization (EUA) expansion and recommendations from the Advisory Committee on Immunization Practices (ACIP) soon for an additional dose of COVID-19 vaccine for patients with specific immunocompromising conditions. We will share more information once final recommendations are available. Please see below for information on ordering additional vaccine for this population when needed.

Supply of both Pfizer and Moderna continues to be plentiful. Before ordering more vaccine for your immunocompromised patients, please consider your patient population and your current inventory, as we want to continue to minimize wasted vaccine. If you need additional vaccine for this patient population, please request additional doses in MIIC using the event titled “Aug 16th and 23rd Delivery Week: Request COVID-19 Vaccine.” We will fulfill these orders as they come in to ensure you receive additional vaccine as soon as possible. You can expect to receive your orders within 2-3 business days. Please contact with questions.

COVID-19 vaccines for people who are pregnant or lactating

COVID-19 vaccination is recommended for all people 12 years and older, including people who are pregnant, breastfeeding, trying to get pregnant now, or might become pregnant in the future. There is a growing body of evidence that demonstrates the safety of COVID-19 vaccines in pregnancy and during breastfeeding. There is also increased concern about the growing risk that COVID-19 disease poses to pregnant women and the fetus. CDC updated the Interim Clinical Considerations for Use of COVID-19 Vaccines: Considerations involving pregnancy, lactation, and fertility on August 11, 2021, with these recommendations. You can also find updates to CDC’s COVID-19 Vaccines While Pregnant or Breastfeeding.

Updated CDC interim clinical considerations for Guillain-Barré syndrome

On August 6, CDC updated the interim clinical considerations for certain populations with the use of the Janssen (Johnson & Johnson) COVID-19 vaccine. In the update, it discusses that people with a history of Guillain-Barré syndrome (GBS) can receive any Food and Drug Administration (FDA)-authorized COVID-19 vaccine. However, given the possible association between the Janssen COVID-19 vaccine and an increased risk of GBS, a patient with a history of GBS and their clinical team should discuss the availability of mRNA COVID-19 vaccines to offer protection against COVID-19.

Any occurrence of GBS following COVID-19 vaccination should be reported to VAERS: Report an Adverse Event. CDC and FDA are continuing to monitor and review cases of GBS among people who receive any FDA-authorized COVID-19 vaccine in the United States and may update the current guidance.

Review the CDC: Interim Clinical Considerations for Use of COVID-19 Vaccines for further details. 

Foreign COVID-19 vaccines in MIIC

CDC has provided codes for the following foreign COVID-19 vaccines. They will be added to MIIC on August 12. Please use these to record any historical dose of vaccine products given internationally.

  • Anhui Zhifei Covid-19 Vaccine
  • CanSino/Beijing Covid-19 Vaccine
  • Coronavac (Sinovac) COVID-19 Vaccine
  • COVAXIN Covid-19 Vaccine
  • COVIVAC Covid-19 Vaccine
  • EpiVacCorona Covid-19 Vaccine
  • Jiangsu Covid-19 Vaccine
  • QazCovid-in COVID-19 Vaccine
  • Sinopharm (BIBP) COVID-19 Vaccine
  • Sputnik Light Covid-19 Vaccine
  • Sputnik V Covid-19 Vaccine

All vaccine codes accepted by MIIC can be found at MIIC Codes for Data Submission and Exchange.

Ensure you are following appropriate clinical guidance for completing vaccine series given outside the U.S. Refer to the CDC Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States: People vaccinated outside the United States.

Notify MDH of any COVID-19 vaccine coordinator changes

During registration, providers were asked to list a primary and back-up COVID-19 vaccine coordinator for their site. MDH uses these coordinators as points of contact for COVID-19 vaccine work. If there have been any changes to your site’s primary or back-up COVID-19 vaccine coordinator, please notify the COVID-19 vaccine distribution team at

COVID-19 vaccination records for patients

As more employers and social settings require proof of vaccination, you may be receiving requests from patients for a certified vaccination record, QR code, or replacement CDC vaccine card. Please do not direct these requests to MDH. We are unable to provide these formats of vaccination records. Your organization can provide your patient with a copy of their MIIC record. Learn more using the Client Search and Printing Immunization Records user guidance.

Patients who contact MDH requesting record of their vaccination are provided a printout of their MIIC record. Record requests are filled within 10-14 business days.

Janssen vaccine availability

Thank you to everyone who has made their excess Janssen inventory available to other providers throughout the state. Together we have redistributed over 22,000 doses of Janssen vaccine since mid-June. As a reminder, the COVID-19 Vaccine Available for Redistribution Smartsheet will no longer have Janssen vaccine available to request as there is no longer excess inventory available for redistribution. We do encourage you to continue to look at your current inventory and report any excess Janssen inventory to the Smartsheet tool as soon as you know you will have excess. We are also looking at options to secure Janssen vaccine from other states. As always, we will update you when Janssen is available again.

Reminder: Extended shelf life

The U.S. Food & Drug Administration (FDA) authorized an extension of the shelf life for the Janssen (Johnson & Johnson) single-shot COVID-19 vaccine from 4.5 months to 6 months.

Vaccine providers should visit Expiry Checker: Janssen COVID-19 Vaccine Under Emergency Use Authorization to confirm the latest expiration dates of vaccine. If the lot number you enter displays the original expiration date, you will want to keep checking as information is still in the process of updating.

New training requirement for COVID-19 vaccine providers

We have recently updated our COVID-19 vaccine provider training and consolidated it into one training with CEUs. Vaccination coordinators and back-ups that are listed in the COVID-19 vaccine provider agreement and are still handling and/or administering vaccine are required to take the updated training, which is now available in MDH’s Learning Management System (LMS). Those who completed the initial training should complete the updated training by October 1, 2021. We strongly encourage any staff handling and administering vaccine to also complete this training.

To access the training, go to Minnesota Department of Health (MDH) Learning Center and create an account for the LMS, if you do not already have one. Click on the course catalog, scroll down to the “COVID-19 Vaccination Provider Training 2021,” and take the training. You will receive a certificate upon completion of this training, which will meet the requirements of tracking your training. You will also receive 0.5 CEUs.

Webinar on building effective messages and vaccine confidence for COVID-19 vaccinations

Health care providers and partners, please join a webinar hosted by the U.S. Department of Health and Human Services and CDC on Monday, August 16 at 4:15 p.m. ET to share their latest messaging strategies and resources, including new methods to address vaccine misinformation and reach underserved populations. They will also discuss CDC resources on new tactics to build vaccine confidence and demand.  

To join the webinar:

By computer

Go to CDC: Zoom - Launch Meeting Passcode: g!52Pn^P

One tap mobile

US: +16692545252,,1615925011#,,,,*56003073#  or +16468287666,,1615925011#,,,,*56003073#

By phone

Dial (for higher quality, dial a number based on your current location): US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373 Webinar ID: 161 592 5011 Passcode: 56003073 International numbers available at CDC Zoom International Dial-in Numbers

H.323/SIP room system

H.323: (US West) or (US East) Meeting ID: 161 592 5011 Passcode: 56003073 SIP: Passcode: 56003073

Webinar on co-administration of COVID-19 and adolescent vaccines

Health care providers and partners, join us on Wednesday, August 18 at noon – 1 p.m. for a webinar to discuss adolescent catch-up immunization. Dr. Nathan Chomilo, State COVID-19 Vaccine Equity Director, will present data on the pediatric immunization gap to highlight the importance of catching kids up on missed routine immunizations. This webinar will also feature Dr. Andrea Singh from Park Nicollet Clinic, who will talk about the success of co-administration at her clinic. We will also cover ACIP recommendations for co-administration, adolescent vaccine recommendations, and how to address vaccine hesitancy with parents of adolescents.

To join the webinar:

  1. Go to Session Information: Adolescent immunizations
  2. Enter your name and email address.
  3. Enter the session password: catchupteens!
  4. Click "Join Now".
  5. For audio, follow the instructions that appear on your screen. You can listen through your computer or via phone. Do not dial in on a phone unless prompted by your selection within Webex.

To join the session by phone only:

Do not use this information if you are participating via the webinar. Follow the instructions on the screen when you login. Call 1-855-282-6330 and enter access code: 146 921 6422.

Find previous bulletins at COVID-19 Vaccine Provider Updates.